Skip to main content

Acorda Therapeutics, Inc.

ACORDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001008848

Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Acorda Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
30
−5 vs. Q4 2022
Shares held
6.50M
+1.28M (+24.4%) vs. Q4 2022
Total value
$3.71M
−$280.2K (−7.0%) vs. Q4 2022
New holders
2
9 more added
Sold out
7
11 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 30 institutions
Q1 2021: 37 institutionsQ2 2021: 37 institutionsQ3 2021: 36 institutionsQ4 2021: 34 institutionsQ1 2022: 34 institutionsQ2 2022: 35 institutionsQ3 2022: 36 institutionsQ4 2022: 36 institutionsQ1 2023: 30 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 15 institutionsQ1 2024: 17 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $3.71M
Q1 2021: $18.0MQ2 2021: $18.1MQ3 2021: $14.7MQ4 2021: $9.48MQ1 2022: $5.42MQ2 2022: $3.08MQ3 2022: $1.91MQ4 2022: $4.09MQ1 2023: $3.71MQ2 2023: $1.94MQ3 2023: $2.30MQ4 2023: $2.33MQ1 2024: $2.13MQ2 2024: $8.00KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ACOR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$8.00K
Q1 202417$2.13M
Q4 202315$2.33M
Q3 202316$2.30M
Q2 202315$1.94M
Q1 202330$3.71M
Q4 202236$4.09M
Q3 202236$1.91M
Q2 202235$3.08M
Q1 202234$5.42M
Q4 202134$9.48M
Q3 202136$14.7M
Q2 202137$18.1M
Q1 202137$18.0M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding ACOR in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Davidson Kempner Capital Management LP1,803,070$1.01M0.02%−592,598−24.7%Reduced
Davidson Kempner Partners1,803,070$1.01M0.03%+1,803,070New
Renaissance Technologies LLC885,292$519.0K0.00%+16,400+1.9%Added
Acadian Asset Management LLC682,638$398.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP218,830$128.2K0.00%+195,759+848.5%Added
Millennium Management LLC174,483$102.0K0.00%−22,943−11.6%Reduced
Vanguard Group Inc159,778$93.6K0.00%+1,459+0.9%Added
Two Sigma Securities, LLC141,152$82.7K0.01%−8,513−5.7%Reduced
BlackRock Inc.135,452$79.4K0.00%−145−0.1%Reduced
Bridgeway Capital Management, LLC76,706$45.0K0.00%00.0%Unchanged
Wells Fargo & Company74,750$43.8K0.00%+20.0%Added
Geode Capital Management, LLC66,693$39.1K0.00%−976−1.4%Reduced
HN Saltoro Capital, LP51,391$23.9K0.07%−57,436−52.8%Reduced
Northern Trust Corp39,114$22.9K0.00%+12,997+49.8%Added
Deutsche Bank AG34,000$19.9K0.00%00.0%Unchanged
State Street Corp31,648$18.5K0.00%00.0%Unchanged
Two Sigma Investments, LP27,082$15.9K0.00%−2,173−7.4%Reduced
Simplex Trading, LLC15,416$9.00K0.00%−9,704−38.6%Reduced
Two Sigma Advisers, LP14,700$8.61K0.00%−300−2.0%Reduced
Simon Quick Advisors, LLC14,370$8.42K0.00%+159+1.1%Added
Tower Research Capital LLC (TRC)11,855$7.00K0.00%+6,186+109.1%Added
HRT Financial LP12,520$7.00K0.00%+12,520New
Morgan Stanley9,575$5.61K0.00%+4,596+92.3%Added
Group One Trading, L.P.6,558$3.84K0.00%−2,989−31.3%Reduced
UBS Group AG6,025$3.53K0.00%−7,277−54.7%Reduced
Russell Investments Group, Ltd.6,000$3.52K0.00%00.0%Unchanged
First Manhattan Co50$290.00%00.0%Unchanged
JPMorgan Chase & Co11$00.00%00.0%Unchanged
Royal Bank of Canada329$00.00%+6+1.9%Added
Advisor Group Holdings, Inc.1$00.00%00.0%Unchanged
Prudential Financial Inc0$00.00%−31,400−100.0%Sold out
United Asset Strategies, Inc.0$00.00%−27,100−100.0%Sold out
Verition Fund Management LLC0$00.00%−13,641−100.0%Sold out
Citigroup Inc0$00.00%−355−100.0%Sold out
IMA Wealth, Inc.0$00.00%−17−100.0%Sold out
JNBA Financial Advisors0$00.00%−1−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−167−100.0%Sold out
Telemetry Investments, L.L.C.––––Not filed